Asset Details
Do you wish to reserve the book?
Endoscopic Management of Early Esophageal Neoplasia: an Emerging Standard
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Endoscopic Management of Early Esophageal Neoplasia: an Emerging Standard
Do you wish to request the book?
Endoscopic Management of Early Esophageal Neoplasia: an Emerging Standard
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Endoscopic Management of Early Esophageal Neoplasia: an Emerging Standard
2011
Overview
Introduction
Endoscopic mucosal resection (EMR) and ablation technologies have markedly changed the treatment of early esophageal neoplasia. We analyzed treatment and outcomes of patients undergoing multimodal endoscopic treatment of early esophageal neoplasia at our institution.
Methods
Records of patients undergoing endoscopic treatment for esophageal low-grade intraepithelial neoplasia (LGIN,
n
= 11), high-grade intraepithelial neoplasia (HGIN,
n
= 24), or T1N0M0 neoplasia (
n
= 10), presenting between 2007 and 2009, were reviewed. Outcomes included eradication of neoplasia/intestinal metaplasia, development of metachronous neoplasia, and progression to surgical resection.
Results
There were 45 patients, 96% male, with a mean age 67 years. The degree of neoplasia prior to intervention was intramucosal (8) or submucosal (2) carcinoma in 10, HGIN in 24, and LGIN in 11. Patients underwent a total of 166 procedures (median 3/patient, range 1–9). These included 120 radiofrequency ablation sessions, 38 EMRs, and 8 cryoablations. Mean follow-up was 21.3 months. Neoplasia and intestinal metaplasia were eradicated in 87.2% and 56.4% of patients, respectively, while 15.4% developed metachronous neoplasia. Three patients underwent esophagectomy. No patient developed unresectable disease or died.
Conclusion
Endoscopic treatment of early esophageal neoplasia is safe and effective in the short term. A minority of treated patients developed recurrent neoplasia, which is usually amenable to further endoscopic therapy. Complications are relatively minor and uncommon. Endoscopic therapy as the initial treatment for early esophageal neoplasia is an emerging standard of care.
Publisher
Springer-Verlag,Springer Nature B.V
Subject
/ Aged
/ Cancer
/ Esophageal Neoplasms - pathology
/ Esophageal Neoplasms - surgery
/ Female
/ Humans
/ Male
/ Medicine
/ Patients
/ Surgery
